Interferon gamma/NADPH oxidase defense system in immunity and cancer
Status PubMed-not-MEDLINE Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
27057461
PubMed Central
PMC4801460
DOI
10.1080/2162402x.2015.1080416
PII: 1080416
Knihovny.cz E-zdroje
- Klíčová slova
- Cellular senescence, DNA damage response, oxidative stress, tumor growth factor beta, tumor immunosurveillance,
- Publikační typ
- časopisecké články MeSH
As a part of cellular pathogen defense, IFNγ triggers induction of NADPH oxidase NOX2, which produces superoxide into phagosomes of immune cells. Recent data show that a similar mechanism can also operate in IFNγ-mediated anticancer control. IFNγ is capable of inducing expression of constitutively active NADPH oxidase NOX4 in tumor cells leading to generation of reactive oxygen species (ROS) damaging DNA, activation of DNA damage response and cell cycle arrest/premature cellular senescence.
Immunology Unit CCP Institute of Molecular Genetics of the ASCR v v i Prague Czech Republic
Laboratory of Cell Reproduction Institute of Microbiology of the ASCR v v i Prague Czech Republic
Zobrazit více v PubMed
Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006; 6:836-48; PMID:17063185; http://dx.doi.org/10.1038/nri1961 PubMed DOI
Hubackova S, Kucerova A, Michlits G, Kyjacova L, Reinis M, Korolov O, Bartek J, Hodny Z. IFN[gamma] induces oxidative stress, DNA damage and tumor cell senescence via TGF[beta]/SMAD signaling-dependent induction of Nox4 and suppression of ANT2. Oncogene 2015; [Epub ahead of print]; PMID:25982278; http://dx.doi.org/10.1038/onc.2015.162 PubMed DOI
Braumuller H, Wieder T, Brenner E, Assmann S, Hahn M, Alkhaled M, Schilbach K, Essmann F, Kneilling M, Griessinger C et al. . T-helper-1-cell cytokines drive cancer into senescence. Nature 2013; 494:361-5; PMID:23376950; http://dx.doi.org/10.1038/nature11824 PubMed DOI
Weyemi U, Lagente-Chevallier O, Boufraqech M, Prenois F, Courtin F, Caillou B, Talbot M, Dardalhon M, Al Ghuzlan A, Bidart JM et al. . ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence. Oncogene 2012; 31:1117-29; PMID:21841825; http://dx.doi.org/10.1038/onc.2011.327 PubMed DOI PMC
Hubackova S, Krejcikova K, Bartek J, Hodny Z. IL1- and TGFbeta-Nox4 signaling, oxidative stress and DNA damage response are shared features of replicative, oncogene-induced, and drug-induced paracrine ‘Bystander senescence’. Aging (Albany NY) 2012; 4:932-51; PMID:23385065 PubMed PMC
Kodama R, Kato M, Furuta S, Ueno S, Zhang Y, Matsuno K, Yabe-Nishimura C, Tanaka E, Kamata T. ROS-generating oxidases Nox1 and Nox4 contribute to oncogenic Ras-induced premature senescence. Genes Cells 2013; 18:32-41; PMID:23216904; http://dx.doi.org/10.1111/gtc.12015 PubMed DOI
Lambeth JD, Kawahara T, Diebold B. Regulation of Nox and Duox enzymatic activity and expression. Free Radical Biol Med 2007; 43:319-31; PMID:17602947; http://dx.doi.org/10.1016/j.freeradbiomed.2007.03.028 PubMed DOI PMC
Weyemi U, Redon CE, Aziz T, Choudhuri R, Maeda D, Parekh PR, Bonner MY, Arbiser JL, Bonner WM. Inactivation of NADPH oxidases NOX4 and NOX5 protects human primary fibroblasts from ionizing radiation-induced DNA damage. Radiat Res 2015; 183:262-70; PMID:25706776; http://dx.doi.org/10.1667/RR13799.1 PubMed DOI PMC
Ameziane-El-Hassani R, Talbot M, de Souza Dos Santos MC, Al Ghuzlan A, Hartl D, Bidart JM, De Deken X, Miot F, Diallo I, de Vathaire F et al. . NADPH oxidase DUOX1 promotes long-term persistence of oxidative stress after an exposure to irradiation. Proc Natl Acad Sci U S A 2015; 112:5051-6; PMID:25848056; http://dx.doi.org/10.1073/pnas.1420707112 PubMed DOI PMC
Fandy TE, Jiemjit A, Thakar M, Rhoden P, Suarez L, Gore SD. Decitabine induces delayed reactive oxygen species (ROS) accumulation in leukemia cells and induces the expression of ROS generating enzymes. Clin Cancer Res 2014; 20:1249-58; PMID:24423613; http://dx.doi.org/10.1158/1078-0432.CCR-13-1453 PubMed DOI PMC